↓ Skip to main content

Cochrane Database of Systematic Reviews

Injection allergen immunotherapy for asthma

Overview of attention for article published in Cochrane database of systematic reviews, August 2010
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

blogs
4 blogs
policy
4 policy sources
twitter
232 tweeters
facebook
3 Facebook pages
wikipedia
4 Wikipedia pages
video
8 video uploaders

Citations

dimensions_citation
432 Dimensions

Readers on

mendeley
238 Mendeley
connotea
1 Connotea
Title
Injection allergen immunotherapy for asthma
Published in
Cochrane database of systematic reviews, August 2010
DOI 10.1002/14651858.cd001186.pub2
Pubmed ID
Authors

Michael J Abramson, Robert M Puy, John M Weiner

Abstract

Allergen specific immunotherapy has long been a controversial treatment for asthma. Although beneficial effects upon clinically relevant outcomes have been demonstrated in randomised controlled trials, there remains a risk of severe and sometimes fatal anaphylaxis. The recommendations of professional bodies have ranged from cautious acceptance to outright dismissal. With increasing interest in new allergen preparations and methods of delivery, we updated the systematic review of allergen specific immunotherapy for asthma.

Twitter Demographics

The data shown below were collected from the profiles of 232 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 238 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Korea, Republic of 2 <1%
Germany 2 <1%
Portugal 1 <1%
United Kingdom 1 <1%
Canada 1 <1%
Unknown 231 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 37 16%
Other 36 15%
Student > Master 29 12%
Student > Bachelor 20 8%
Student > Ph. D. Student 18 8%
Other 54 23%
Unknown 44 18%
Readers by discipline Count As %
Medicine and Dentistry 118 50%
Agricultural and Biological Sciences 18 8%
Immunology and Microbiology 12 5%
Nursing and Health Professions 9 4%
Social Sciences 7 3%
Other 26 11%
Unknown 48 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 230. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2021.
All research outputs
#99,417
of 19,176,496 outputs
Outputs from Cochrane database of systematic reviews
#191
of 11,944 outputs
Outputs of similar age
#371
of 134,722 outputs
Outputs of similar age from Cochrane database of systematic reviews
#1
of 118 outputs
Altmetric has tracked 19,176,496 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,944 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 134,722 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.